MEN1 and pituitary tumor: The analysis of our MEN1 database confirmed PHPT as the most common manifestation of the syndrome, reaching a penetrance of over 95% after the age of 55, followed by GEP-NETs (about 60%) and pituitary tumours (about 52%), respectively.